海外の治験の状況「HPV」での検索結果
61件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
- Infections, Papillomavirus;Infections, Papillomavirus;Infections, Papillomavirus;Infections, Papillomavirus
- Australia, Canada, Mexico, Netherlands, Peru, Philippines, Portugal, Russian Federation, Singapore, Thailand, United Kingdom, United States
- 2010-08-26
Not recruiting
- Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)
- HPV;Cervical Cancer;Premalignancy Anogenital Warts
- Colombia, Peru, United States
- 2005-11-28
Not recruiting
- Knowledge and Attitude About HPV Vaccines
- Knowledge;Attitude;Behavior
- Brazil
- 2010-01-05
Not recruiting
- Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
- Infections, Papillomavirus;Infections, Papillomavirus;Infections, Papillomavirus;Infections, Papillomavirus
- Australia, Belgium, Brazil, Canada, Finland, Germany, Italy, Mexico, Philippines, Puerto Rico, Spain, Taiwan, Thailand, United Kingdom, United States
- 2005-07-20
Not recruiting
- Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
- Infections, Papillomavirus
- Brazil, Canada, United States
- 2005-07-12
Not recruiting
- Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
- Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection;Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection;Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection;Cervical Cancer;Vulvar Cancer;Vaginal Cancer;Genital Warts;Human Papillomavirus Infection
- Brazil, Canada, Chile, Colombia, Denmark, Hong Kong, Japan, Korea, Republic of, Mexico, New Zealand, Norway, Peru, Puerto Rico, Sweden, Taiwan, Thailand, United States
- 2007-10-12
Not recruiting
- Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women
- Infections, Papillomavirus
- Brazil, Canada, Puerto Rico, United States
- 2008-05-30
Not Recruiting
- A RANDOMIZED, INTERNATIONAL, DOUBLE-BLINDED (WITH IN-HOUSE BLINDING), CONTROLLED WITH GARDASIL™, DOSE-RANGING, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY STUDY OF A MULTIVALENT HUMAN PAPILLOMAVIRUS (HPV) L1 VIRUS-LIKE PARTICLE (VLP) VACCINE ADMINISTERED TO 16- TO 26-YEAR-OLD WOMEN
- -B977 Papillomavirus as the cause of diseases classified to other chapters Papillomavirus as the cause of diseases classified to other chapters;Papillomavirus as the cause of diseases classified to other chapters
- Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Germany, Japan, Korea South, Mexico, New Zealand, Norway, Peru, Sweden, Taiwan, Thailand, United States
- 2014-03-24
Not recruiting
- Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study
- Infections, Papillomavirus;Infections, Papillomavirus;Infections, Papillomavirus;Infections, Papillomavirus
- Brazil
- 2011-08-12
Not recruiting
- Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
- Cervical Intraepithelial Neoplasia;Papillomavirus Infection;Cervical Intraepithelial Neoplasia;Papillomavirus Infection;Cervical Intraepithelial Neoplasia;Papillomavirus Infection;Cervical Intraepithelial Neoplasia;Papillomavirus Infection
- Colombia, Germany, Honduras, Panama, Taiwan
- 2006-04-19
